Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Immunol Rev. 2019 Jul;290(1):114–126. doi: 10.1111/imr.12768

TABLE 3.

Modified summary of CRES/ICANS grading scales

Institution Grade 1 Grade 2 Grade 3 Grade 4
CTCAE 5.0 Mild symptoms (brief partial seizure w/o LOC) Symptoms limiting instrumental ADL (brief generalized seizure) Symptoms limiting self-care ADL (multiple seizures despite medical care); New onset cerebral edema Life threatening symptoms
CARTOX 7-9 CARTOX score (mild impairment) 3-6 CARTOX score (moderate impairment) 0-2 CARTOX score (severe impairment); seizures responsive to benzodiazepine; stage 1-2 papilledema Critical/obtunded condition; Generalized seizures or non-convulsive status epilepticus; stage 3-5 papilledema or cerebral edema
ASBMT Adult 7-9 ICE score; awaken spontaneously 3-6 ICE score; awaken to voice 0-2 ICE score; awaken to tactile stimulus; seizure that resolves with intervention; focal edema on neuroimaging Life threatening symptoms
ASBMT Pediatrica CAPD 1-8 CAPD 1-8 CAPD ≥9 Unable to perform CAPD

The CTCAE scale incorporates encephalopathy, seizure, dysphagia, tremor, headache, confusion, depressed level of consciousness and cerebral edema; CARTOX criteria incorporates Neurologic Assessment Score (CARTOX-10 score), elevated ICP, seizure or motor weakness. ASBMT criteria are based on ICE score (modified CARTOX-10 evaluation), level of consciousness, seizures, motor findings, and elevated ICP.

Abbreviations: ADL, activities of daily living; LOC, loss of consciousness.

*

ASBMT pediatric criteria are for children <12 and include all of the adult criteria with the addition of the CAPD score based off the Cornell delirium assessments.